Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Med-tech in the minority, but firms draw investor interest

Jan. 14, 2008

By Larry Haimovitch

New strategies add to weaponry winning against some cancers

Dec. 1, 2007

By Larry Haimovitch

New ophthalmic technologies drive sector positioning battle

Nov. 14, 2007

By Larry Haimovitch

Growth in technical weaponry targets No. 2 cause of death

Nov. 2, 2007

By Larry Haimovitch

Radiosurgery company growth sparked by added applications

Oct. 11, 2007

By Larry Haimovitch

Radiosurgery company growth sparked by added applications

Oct. 9, 2007

By Larry Haimovitch

Conference tackles pandemic fueled by diabetes and aging

Oct. 1, 2007

By Larry Haimovitch

Conference tackles PAD pandemic fueled by diabetes, aging

Oct. 1, 2007

By Larry Haimovitch

Some firms swim strong against tide of med-tech consumables

Sep. 14, 2007

By Larry Haimovitch

Advances in ‘cardio peripherals’ driving robust growth for ev3

Sep. 12, 2007

By Larry Haimovitch

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...